April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Intraocular pressure (IOP) measured with the Ocular Response Analyzer is a better predictor of glaucoma progression than Goldmann IOP in the United Kingdom Glaucoma Treatment Study (UKGTS).
Author Affiliations & Notes
  • Gerassimos Lascaratos
    NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom
  • David F Garway-Heath
    NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom
  • Richard A Russell
    Department of Optometry and Visual Science, City University, London, United Kingdom
  • David Paul Crabb
    Department of Optometry and Visual Science, City University, London, United Kingdom
  • Haogang Zhu
    Department of Optometry and Visual Science, City University, London, United Kingdom
  • Cornelia Hirn
    NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom
  • Aachal Kotecha
    NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom
  • Katsuyoshi Suzuki
    NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom
  • Footnotes
    Commercial Relationships Gerassimos Lascaratos, Allergan (F); David Garway-Heath, Alcon (C), Alcon (R), Alimera (C), Allergan (C), Allergan (F), Allergan (R), Bausch&Lomb (C), Bausch&Lomb (R), Carl Zeiss Meditec (F), Forsight (C), Heidelberg Engineering (F), Optovue (F), Pfizer (F), Quark (C), Sensimed (C), Teva Pharmaceutica (C); Richard Russell, None; David Crabb, Allergan (F), MSD (F); Haogang Zhu, None; Cornelia Hirn, None; Aachal Kotecha, None; Katsuyoshi Suzuki, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 128. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Gerassimos Lascaratos, David F Garway-Heath, Richard A Russell, David Paul Crabb, Haogang Zhu, Cornelia Hirn, Aachal Kotecha, Katsuyoshi Suzuki, ; Intraocular pressure (IOP) measured with the Ocular Response Analyzer is a better predictor of glaucoma progression than Goldmann IOP in the United Kingdom Glaucoma Treatment Study (UKGTS).. Invest. Ophthalmol. Vis. Sci. 2014;55(13):128.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Intraocular pressure (IOP) and central corneal thickness (CCT) are important risk factors for glaucoma progression. However, it is uncertain whether CCT risk is independent or mediated through IOP measurement error. The Ocular Response Analyzer (ORA) and Dynamic Contour Tonometer (DCT) make IOP measurements less affected by corneal biomechanics than the Goldmann applanation tonometer (GAT). Our hypothesis was that the correlation between the rate of visual field (VF) loss and ORA IOP and DCT IOP is stronger than with GAT IOP.

Methods: 516 previously untreated open angle glaucoma patients were monitored over 2 years in the United Kingdom Glaucoma Treatment Study with VF testing, and tonometry with the GAT, DCT and ORA at 11 visits. The eye with the most negative baseline mean deviation (MD) was selected and only eyes with VFs over at least 5 visits were included. Pearson’s correlation coefficient (R) was used to measure the strength of the relationship between median follow-up IOP [GAT, DCT, corneal compensated IOP (IOPcc) and Goldmann correlated IOP (IOPg)] and MD slope. IOP models, with CCT, corneal hysteresis (CH), corneal resistance factor (CRF) and axial length (AL) included as covariates, were compared using the Akaike Information Criterion (AIC) and Akaike weights (AWs). Data analysis was performed with the statistical software R.

Results: 342 eyes of 342 patients were included. Pearson’s R of the MD slope against median GAT IOP, DCT IOP, IOPcc and IOPg was 0.263, 0.230, 0.294 and 0.244, respectively (P<0.001 in all cases). The AIC values (AWs) for the GAT, DCT, IOPcc and IOPg models were 1006 (0.039), 1012 (0.002), 1000 (0.953) and 1010 (0.007), respectively. IOPcc had the highest AW, suggesting it had the highest probability (95.3%) of being the best predictor of VF progression. Following inclusion of CCT, CH, CRF and AL in each IOP model, a backward stepwise AIC approach was applied to remove non-significant predictors; the best two models were IOPcc alone (AIC=1000, AW=0.69) and GAT IOP with CH (AIC=1001, AW=0.31). CCT did not contribute to any model and, on its own, was not correlated to the MD slope (R=-0.0047).

Conclusions: IOP is a relatively poor predictor of glaucomatous progression, but IOPcc and GAT IOP with CH measured by the ORA, were the best models of VF progression in this study.

Keywords: 568 intraocular pressure • 466 clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials • 629 optic nerve  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×